Cargando…
A KCNB1 gain of function variant causes developmental delay and speech apraxia but not seizures
Objective: Numerous pathogenic variants in KCNB1, which encodes the voltage-gated potassium channel, K(V)2.1, are linked to developmental and epileptic encephalopathies and associated with loss-of-function, -regulation, and -expression of the channel. Here we describe a novel de novo variant (P17T)...
Autores principales: | Veale, Emma L., Golluscio, Alessia, Grand, Katheryn, Graham, John M., Mathie, Alistair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810754/ https://www.ncbi.nlm.nih.gov/pubmed/36618935 http://dx.doi.org/10.3389/fphar.2022.1093313 |
Ejemplares similares
-
The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels
por: Cunningham, Kevin P., et al.
Publicado: (2021) -
Identification of an Identical de Novo SCAMP5 Missense Variant in Four Unrelated Patients With Seizures and Severe Neurodevelopmental Delay
por: Jiao, Xianru, et al.
Publicado: (2020) -
Speech and orofacial apraxias in Alzheimer's disease
por: Cera, Maysa Luchesi, et al.
Publicado: (2013) -
Social Robotics in Therapy of Apraxia of Speech
por: Castillo, José Carlos, et al.
Publicado: (2018) -
Treatment for Apraxia of Speech in Nonfluent Variant Primary Progressive Aphasia
por: Henry, M. L., et al.
Publicado: (2013)